Veris Residential (VRE) files Form 144/A for 10,204-share sale

Rhea-AI Filing Summary

Veris Residential, Inc. (VRE) filed a Form 144/A reporting a proposed sale of 10,204 common shares through Morgan Stanley Smith Barney LLC with an approximate aggregate market value of $153,468.16, targeted for 10/02/2025. The filer states these shares were acquired in an open-market purchase on 07/27/2018 and paid for in cash.

The filing also lists multiple recent dispositions by related entities MIRELF VI REIT INVESTMENT II, LLC and MIRELF VII US SECURITIES LLC between 09/09/2025 and 10/01/2025, with individual trade proceeds ranging from about $232,632 to $1,846,956.29. The notice includes the seller's standard representation that no undisclosed material adverse information is known.

Positive

• Rule 144 notice filed for a clear, brokered sale of 10,204 shares
• Securities were paid in cash and were acquired in the open market on 07/27/2018

Negative

• Multiple large recent dispositions by related entities between 09/09/2025 and 10/01/2025 with gross proceeds up to $1,846,956.29
• No 10b5-1 plan adoption date disclosed, so trading-plan protection is not asserted in this notice

Insights

Equity Capital Markets Analyst

Planned officer/affiliate sale is modest but follows significant recent dispositions.

The planned sale of 10,204 shares ($153,468.16) is a direct notice under Rule 144 and will likely trade through a broker on the NYSE. The shares were purchased on 07/27/2018 in the open market, which indicates these are not freshly issued securities.

Related entities recorded multiple large sales from 09/09/2025 to 10/01/2025 with gross proceeds per trade up to $1.85M, which may reflect portfolio rebalancing or liquidity needs; monitor near-term daily volume and price impact around 10/02/2025.

Corporate Governance Specialist

Filing follows Rule 144 mechanics and includes the required certification about material non-public information.

The signature block includes the standard attestation that the seller is unaware of undisclosed material adverse information, and mentions Rule 10b5-1 only if a plan was adopted. No trading-plan date is disclosed, so trading-plan protections are not asserted here.

Investors should note the absence of a disclosed 10b5-1 adoption date; if monitoring insider liquidity programs, look for future filings that state plan adoption or amendment dates.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK
Filer CCC
Previous Accession Number Of The Filing
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10204	153468.16	93421769	10/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/27/2018	Open Market Purchase	Open Market			10204	07/27/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	10/01/2025	32040	482890.86
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	10/01/2025	42960	647471.64
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/18/2025	41018	634413.10
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/18/2025	30592	473157.29
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/17/2025	14989	232632.28
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/17/2025	20097	311909.46
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/16/2025	40355	622601.54
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/16/2025	54108	834784.42
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/15/2025	26600	416276.70
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/15/2025	19838	310454.78
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/12/2025	79724	1272734.52
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/12/2025	106897	1706531.26
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/11/2025	85440	1373003.71
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/11/2025	114560	1840956.29
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	85920	1378491.89
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	64080	1028093.11
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	64080	1032924.74
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	85920	1384970.29

144/A: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Veris Residential (VRE) report on Form 144/A?

The filing notifies a proposed sale of 10,204 common shares through Morgan Stanley Smith Barney LLC with aggregate market value $153,468.16 planned for 10/02/2025.

When were the shares being sold originally acquired?

The filing states the shares were acquired via an open-market purchase on 07/27/2018 and paid in cash.

Have related entities recently sold VRE shares?

Yes. Multiple sales by MIRELF VI REIT INVESTMENT II, LLC and MIRELF VII US SECURITIES LLC occurred between 09/09/2025 and 10/01/2025, with individual gross proceeds ranging from ~$232k to ~$1.85M.

Will the planned sale occur on an exchange?

Yes. The notice lists the NYSE as the named securities exchange for the proposed sale.

Does the filer assert a Rule 10b5-1 trading plan?

No trading-plan adoption date is provided in the notice; the filing only references the Rule 10b5-1 mechanics in the attestation language.